Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioma 2Meningeal Carcinomatosis 1Glioblastoma 1

Interventions

Topotecan 3Radiotherapy 3Pemetrexed 3osimertinib 2WP 744 2Radiation 2Busulfan 2AZD3759 2tipifarnib 1sintilimab 1pembrolizumab 1peginterferon alfa-2b 1omburtamab I-131 1mafosfamide 1immunotoxin LMB-7 1gallium citrate 1azeliragon 1avelumab 1adavosertib 1Vitamin B 12 1Vinorelbine 1Trastuzumab 1Temozolomide 1Specimen Handling 1Rituximab 1Pentetic Acid 1Melphalan 1Magnetic Resonance Spectroscopy 1Interferons 1Immunotherapy, Adoptive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Meningeal Carcinomatosis × azeliragon × Clear all
NCT06724926 2026-05-18

Concurrent Azeliragon With Craniospinal Irradiation

NYU Langone Health

Phase 1 Active not recruiting
21 enrolled
CNS

Glioma, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡